Entities / Company
Insulet (United States).
insulin delivery device company
- Reports this week
- 0
- Active events
- 0
- Connections
- 53
What's happening
Gone quiet
No new reports in 90+ days-
Insulet (United States) was trading at a more expensive price relative to its industry peers on June 28, 2025.Speculative1 report
-
Medicare spending cuts are affecting diabetes device companies like Insulet and Dexcom.Speculative2 reports1 development inside
-
Insulet (a U.S. company) was involved in a development concerning Quantum Computing on July 17, 2025.Some support1 report
-
Insulet Corporation, headquartered in Acton, Massachusetts, outperformed both the S&P 500 Index and the Health Care Select Sector SPDR Fund on July 24, 2025.Some support2 reports
-
Insulet stock underperformed the broader market on August 7, 2025.Some support1 report
-
Insulet developed and marketed the Omnipod system and integrated it with the Personal Diabetes Manager on August 11, 2025.Some support1 report
-
Insulet management is scheduled to present at conferences in Boston and New York City on August 19, 2025.Some support1 report
-
Insulet introduced Omnipod 5 in Italy, Denmark, Finland, Norway, and Sweden, alongside receiving FDA clearance for type 2 label expansion.Some support2 reports
-
Insulet stock significantly outperformed the broader market index on August 26, 2025.Some support1 report
-
Eric Benjamin was appointed Chief Operating Officer and Manoj Raghunandanan was appointed Chief Growth Officer at Insulet on August 26, 2025.Some support2 reports
-
Zacks Investment Research provided stock analysis and ratings for Insulet (Q104480795), which is part of the Omnipod Insulin Management System (PDM), on August 27, 2025.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Insulet (United States) this week
News at the entities that move Insulet (United States) most-
Bank of America OperationalGoldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Moves Insulet (United States)
-
Dexcom OperationalTandem Mobi utilizes Dexcom G7 technology for monitoring.Moves Insulet (United States)
-
Eric StructuralEric Dane was identified as the father of Billie.Moves Insulet (United States)
-
Wells Fargo Mentioned togetherWells Fargo upgraded Sweetgreen stock to overweight from equal weight on September 28, 2026.Moves Insulet (United States)
-
Denmark Shared contextZealand Pharma A/S appointed Danske Bank as lead manager for its share buy-back program in the Danish market.Moves Insulet (United States)
-
Finland Shared contexteasyJet is launching new winter routes to destinations including Finland, Hurghada, Copenhagen, Barcelona, and Berlin.Moves Insulet (United States)
Connections
The 6 strongest of 53, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Dexcom Operational
The companies actively compete in the patient monitoring sector while also achieving functional integration between their respective products.
-
Eric Structural
Eric serves as the Chief Operating Officer of Insulet and was involved in launching key Omnipod products.
-
Bank of America Operational
Bank of America analysts have inquired about Insulet's growth strategy and acceleration in type 2 diabetes treatment.
-
Denmark Shared context
Insulet operates and introduces its products within the market of Denmark.
-
Wells Fargo Mentioned together
Wells Fargo analysts have shown interest in Insulet's customer starts and general U.S. growth trends.
-
Finland Shared context
Insulet operates and launched its Omnipod 5 product within the market of Finland.
History
Events by the month they beganJune 2026
12 events- On August 14, 2025, financial institutions inquired about market trends, including type 2 diabetes acceleration, U.S. growth variability, and international growth drivers.
- Insulet (United States) was trading at a more expensive price relative to its industry peers on June 28, 2025.
- Medicare spending cuts are affecting diabetes device companies like Insulet and Dexcom.
- Insulet (a U.S. company) was involved in a development concerning Quantum Computing on July 17, 2025.
- Insulet Corporation, headquartered in Acton, Massachusetts, outperformed both the S&P 500 Index and the Health Care Select Sector SPDR Fund on July 24, 2025.
- Insulet stock underperformed the broader market on August 7, 2025.
- Insulet developed and marketed the Omnipod system and integrated it with the Personal Diabetes Manager on August 11, 2025.
- Insulet management is scheduled to present at conferences in Boston and New York City on August 19, 2025.
- Insulet introduced Omnipod 5 in Italy, Denmark, Finland, Norway, and Sweden, alongside receiving FDA clearance for type 2 label expansion.
- Insulet stock significantly outperformed the broader market index on August 26, 2025.
- Eric Benjamin was appointed Chief Operating Officer and Manoj Raghunandanan was appointed Chief Growth Officer at Insulet on August 26, 2025.
- Zacks Investment Research provided stock analysis and ratings for Insulet (Q104480795), which is part of the Omnipod Insulin Management System (PDM), on August 27, 2025.